Pseudoxanthoma Elasticum Clinical Trial
Official title:
Genetic Analysis of Patients With Pseudoxanthoma Elasticum (PXE)
This study will characterize the gene mutations responsible for pseudoxanthoma elasticum
(PXE) and correlate them with disease manifestations in males and females. PXE is an
inherited disorder that affects the connective tissue in some parts of the body. Calcium and
other minerals are deposited in the connective tissue, causing changes in the skin, eyes,
cardiovascular system and gastrointestinal system. Some effects of PXE can cause serious
medical problems, while others have less impact. Symptoms often appear earlier and are more
severe in females than in males, but there is no way to predict how the disorder will
progress in any given individual.
Candidates for this study are recruited through PXE International, an organization that
provides patient support and supports research on the disease. The organization collects
biological samples and medical information on patients and family members to help further
research on the disease. Families that have samples from the patient, both parents, and at
least one sibling may be eligible for this study. Grandparents and extended family members
may be included in certain instances.
Participants provide a blood sample, a sample of cells scraped from the inside of the cheek
(buccal cells) and a medical history. The samples are analyzed for gene variants and the
findings are correlated with disease signs and symptoms.
...
Background:
- Pseudoxanthoma elasticum (PXE) is an autosomal recessive genetic disorder characterized
by mutations in the ATP-binding cassette transporter, ABCC6.
- PXE while it is known that patients have two mutated alleles of the ABCC6 gene,
significant questions remain about the segregation of the disease, the presentation in
males versus females and the correlation of mutation to clinical phenotype.
Objectives:
- The objective is to examine the role of variants in the ABCC6 gene in PXE.
Eligibility:
- Samples from study participants were obtained through the PXE International BioBank.
- Families were selected that have samples from both parents and at least one sibling in
addition to the proband.
Design:
- Participants DNA was sequenced to identify variants and genotyped for linked markers to
follow the segregation of mutant alleles and compare the results with the clinical outcomes.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02537054 -
Intravitreal Aflibercept for Therapy of Patients With Pseudoxanthoma Elasticum (PXE)
|
Phase 2 | |
Completed |
NCT05569252 -
A Study of DS-1211b in Individuals With PseudoXanthoma Elasticum
|
Phase 2 | |
Recruiting |
NCT05662085 -
Progression Rate of Pseudoxanthoma Elasticum-associated Choroidal and Retinal Degeneration
|
||
Completed |
NCT03070860 -
What's Happen Under the Calcification Process in Pseudoxanthoma Elasticum
|
N/A | |
Completed |
NCT01446393 -
Functional and Structural Characterization of Arteriopathy in Pseudoxanthoma Elasticum (PXE)
|
N/A | |
Completed |
NCT00470977 -
Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy
|
Phase 1/Phase 2 | |
Recruiting |
NCT03758534 -
Natural History of GACI With or Without ARHR2 or PXE
|
||
Recruiting |
NCT05734196 -
The ENERGY Study: Evaluation of Safety and Tolerability of INZ-701 in Infants With ENPP1 Deficiency or ABCC6 Deficiency
|
Phase 1 | |
Not yet recruiting |
NCT06462547 -
ADAPT Study: Long-term Safety Study of INZ-701 in Patients With ENPP1 Deficiency and ABCC6 Deficiency
|
Phase 2 | |
Recruiting |
NCT01446380 -
Phenotypic Expressions in a French Pseudoxanthoma-Elasticum Cohort
|
N/A | |
Recruiting |
NCT03813550 -
Intestinal Microbiota and Vitamin K Levels in PXE Patients (IMPROVE Study)
|
N/A | |
Not yet recruiting |
NCT03364504 -
Biological Collection of Kidney Cells
|
N/A | |
Active, not recruiting |
NCT02108392 -
Characterization of Pseudoxanthoma Elasticum
|
||
Recruiting |
NCT01731080 -
Arterial Wall Calcium Load in Pseudoxanthoma Elasticum
|
N/A | |
Completed |
NCT00555113 -
Evolution of Visual Impairment During Pseudoxanthoma Elasticum
|
N/A | |
Withdrawn |
NCT04441671 -
Oral Pyrophosphate Absorption in PXE Disease
|
Phase 2 | |
Recruiting |
NCT04868578 -
PPI Supplementation to Fight ECtopIc Calcification in PXE
|
N/A | |
Completed |
NCT05025722 -
Pseudoxanthoma Elasticum (PXE) Natural History Biomarkers in PXE Individuals and Their Biological Non-PXE Siblings
|
||
Completed |
NCT01525875 -
Magnesium Supplements In The Treatment Of Pseudoxanthoma Elasticum (PXE)
|
Phase 2 | |
Completed |
NCT05246189 -
Employment of Patients With Pseudoxanthoma Elasticum
|